Cover Image
市場調查報告書

心臟瓣膜的全球市場:2016∼2020年

Global Heart Valves Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 361430
出版日期 內容資訊 英文 67 Pages
訂單完成後即時交付
價格
Back to Top
心臟瓣膜的全球市場:2016∼2020年 Global Heart Valves Market 2016-2020
出版日期: 2016年06月08日 內容資訊: 英文 67 Pages
簡介

心臟瓣是為了置換有缺陷的心臟瓣膜所採用的人工心血管醫療設備。全球醫療設施,實施每年大概30萬件心臟瓣膜置換手術。全球心臟瓣膜市場,預計2016∼2020年,以年複合成長率14.28%擴大。

到本報告提供全球心臟瓣膜市場現狀與2020年預測,市場規模與銷售趨勢,各地區趨勢,以及主要供應商的競爭環境與市場佔有率趨勢彙整。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 成本分析

  • 瓣膜置換術的成本分析

第7章 各產品市場區隔

  • 機械瓣膜
  • 組織瓣膜
  • 經導管心臟瓣膜

第8章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第9章 推動市場的要素

  • 心臟瓣膜疾病的發病率
  • 微創手術的引進
  • 經導管瓣膜置換技術的使用
  • 高齡化

第10章 促進要素的影響

第11章 市場課題

  • 潛在併發症風險
  • 熟練人員的不足
  • 高價的心臟瓣膜置換術
  • 嚴格的相關法規

第12章 促進要素與課題的影響

第13章 市場趨勢

第14章 供應商環境

  • 競爭模式
  • 2015年的市場佔有率分析
  • 主要供應商
  • 其他值得注意的供應商

第15章 附錄

第16章 關於Technavio

目錄
Product Code: IRTNTR9025

About the Heart Valves Market

Heart valves are prosthetic cardiovascular medical devices used to replace a defective heart valve. They can be biological, tissue or mechanical. Manufacturers develop mechanical heart valves from synthetic materials such as pyrolytic carbon, titanium alloy, and cobalt-based alloys and tissue heart valves from bovine, porcine, and human tissues. They also develop transcatheter heart valves with a combination of tissue and synthetic materials. Devices developed using human tissues are known as allografts or homografts. Medical personnel implant transcatheter heart valves through the transfemoral approach (via the femoral artery) and transapical approach (via a small chest incision). Medical facilities worldwide perform about 300,000 heart valve replacement procedures each year.

Technavio's analysts forecast the global heart valves market to grow at a CAGR of 14.28% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global heart valves market for 2016-2020. To calculate the market size, we consider revenue generated from the sales of prosthetic heart valve products such as:

  • Mechanical heart valves: Caged ball, tilting disc, and bileaflet valves
  • Tissue heart valves: Stented and stentless tissue valves
  • Transcatheter heart valves: Transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR) devices

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Heart Valves Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Edwards Lifesciences
  • LivaNova
  • Medtronic
  • St. Jude Medical

Other Prominent Vendors

  • Abbott Laboratories
  • Braile Biomedica
  • Cardious
  • Colibri Heart Valve
  • corlife OHG
  • JenaValve Technology
  • Lepu Medical Technology (Beijing)
  • Meril Life Sciences
  • Neovasc
  • ON-X Life Technologies
  • Pulmonx
  • Roskardioinvest
  • SYMETIS

Market driver

  • Implementation of minimally invasive procedures
  • For a full, detailed list, view our report

Market challenge

  • v
  • For a full, detailed list, view our report

Market trend

  • Use of stentless tissue valves
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Cost analysis

  • Cost analysis of valve replacement procedures

PART 07: Market segmentation by product

  • Global mechanical heart valves market
  • Global tissue heart valves market
  • Global transcatheter heart valves market

PART 08: Geographical segmentation

  • Heart valves market in Americas
  • Heart valves market in EMEA
  • Heart valves market in APAC

PART 09: Market drivers

  • Incidence of heart valve diseases
  • Implementation of minimally invasive procedures
  • Use of transcatheter valve replacement technology
  • Rise in older population

PART 10: Impact of drivers

PART 11: Market challenges

  • Risk of potential complications
  • Lack of skilled personnel
  • Expensive heart valve replacement procedures
  • Stringent regulatory framework

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Focus on US
  • Increase in M&A
  • Use of stentless tissue valves
  • Development of novel heart valves

PART 14: Vendor landscape

  • Competitive scenario
  • Market share analysis 2015
  • Key vendors
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global heart valves market 2015-2020 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Cost comparison of heart valve replacement procedures (high-risk group)
  • Exhibit 05: Global heart valves market segmentation by product
  • Exhibit 06: Global heart valves market segmentation by product 2015
  • Exhibit 07: Global heart valves market segmentation by product 2020
  • Exhibit 08: Global heart valves market segmentation by product 2015-2020
  • Exhibit 09: Global mechanical heart valves market segmentation by type
  • Exhibit 10: Characteristics of mechanical valves
  • Exhibit 11: Global mechanical heart valves market 2015-2020 ($ millions)
  • Exhibit 12: Global tissue heart valves market segmentation by type 2015
  • Exhibit 13: Global tissue heart valves market 2015-2020 ($ billion)
  • Exhibit 14: Global transcatheter heart valves market by type 2015
  • Exhibit 15: Global transcatheter heart valves market 2015-2020 ($ billions)
  • Exhibit 16: Global heart valves market segmentation by geography 2015
  • Exhibit 17: Global heart valves market segmentation by geography 2020
  • Exhibit 18: Global heart valves market segmentation by geography 2015-2020
  • Exhibit 19: Heart valves market in Americas 2015-2020 ($ billions)
  • Exhibit 20: Heart valves market in EMEA 2015-2020 ($ billions)
  • Exhibit 21: Heart valves market in APAC 2015-2020 ($ billions)
  • Exhibit 22: Impact of drivers
  • Exhibit 23: Impact of drivers and challenges
  • Exhibit 24: Major acquisitions 2015
  • Exhibit 25: Ranking of top vendors in global tissue heart valves market 2015
  • Exhibit 26: Ranking of top vendors in global tissue heart valves market 2015
  • Exhibit 27: Ranking of top vendors in global tissue heart valves market 2015
  • Exhibit 28: Edwards Lifesciences: Business segmentation by revenue 2015
  • Exhibit 29: Edwards Lifesciences: Business segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 30: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment 2013-2015 ($ millions)
  • Exhibit 31: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment in US 2013-2015 ($ millions)
  • Exhibit 32: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment in ROW 2013-2015 ($ millions)
  • Exhibit 33: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment 2013-2015 ($ millions)
  • Exhibit 34: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment in US 2013-2015 ($ millions)
  • Exhibit 35: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment in ROW 2013-2015 ($ millions)
  • Exhibit 36: Edwards Lifesciences: Key takeaways
  • Exhibit 37: LivaNova: Revenue of cardiac surgery segment by geography 2015
  • Exhibit 38: LivoNova: Key takeaways
  • Exhibit 39: Medtronic: Product portfolio
  • Exhibit 40: Medtronic: Product segmentation by revenue 2015
  • Exhibit 41: Medtronic: Key takeaways
  • Exhibit 42: St. Jude Medical: Product portfolio
  • Exhibit 43: St. Jude Medical: Revenue and YoY growth of structural heart segment 2013-2015 ($ millions)
  • Exhibit 44: St. Jude Medical: Key takeaways
  • Exhibit 45: Other prominent vendors
Back to Top